-
Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer
de Ruiter, B. M., van Hattum, J. W., Lipman, D., de Reijke, T. M., van Moorselaar, R. J. A., van Gennep, E. J., Maartje Piet, A. H., Donker, M., van der Hulle, T., Voortman, J., Oddens, J. R., Hulshof, M. C. C. M. & Bins, A. D., Nov 2022, In: European Urology. 82, 5, p. 518-526 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice
de Ruiter, B-M., van de Kamp, M. W., van Steenbergen, J. P. Z., Franckena, M., Boormans, J. L., de Feijter, J. M., Bins, A. D., Hulshof, M. C. C. M., de Reijke, T. M., Schaake, E. & Oddens, J. R., 1 May 2022, In: European urology open science. 39, p. 7-13 7 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Bladder-sparing chemoradiotherapy combined with immune checkpoint inhibition for locally advanced urothelial bladder cancer—a review
van Hattum, J. W., de Ruiter, B-M., Oddens, J. R., Hulshof, M. C. C. M., de Reijke, T. M. & Bins, A. D., 1 Jan 2022, In: Cancers. 14, 1, 38.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications
